BESREMi is a preferred, FDA-approved option for both symptomatic low- and high-risk polycythemia vera patients. In the polycythemia vera space, BESREMi faces competition from drugs like ruxolitinib, a ...

Nearly every mass-market brand has at least one three-row SUV. Cars.com recently compared seven of them in our 2020 3-Row SUV Challenge, for which I served as one of three judges. The all-new ...